IOL CHEMICALS & PHARM. | AMBALAL SARABHAI | IOL CHEMICALS & PHARM./ AMBALAL SARABHAI |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 137.0 | 9.6% | View Chart |
P/BV | x | 1.5 | 2.8 | 53.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. AMBALAL SARABHAI |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
AMBALAL SARABHAI Mar-23 |
IOL CHEMICALS & PHARM./ AMBALAL SARABHAI |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 39 | 1,376.2% | |
Low | Rs | 272 | 20 | 1,337.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 22.2 | 1,699.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.4 | 1,636.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.8 | 1,745.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 17.1 | 1,503.1% | |
Shares outstanding (eoy) | m | 58.71 | 76.63 | 76.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.3 | 80.2% | |
Avg P/E ratio | x | 17.1 | 20.5 | 83.3% | |
P/CF ratio (eoy) | x | 12.8 | 16.4 | 78.1% | |
Price / Book Value ratio | x | 1.6 | 1.7 | 90.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,274 | 1,044.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 252 | 666.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,703 | 1,302.0% | |
Other income | Rs m | 256 | 125 | 205.1% | |
Total revenues | Rs m | 22,427 | 1,828 | 1,227.1% | |
Gross profit | Rs m | 2,257 | 78 | 2,893.2% | |
Depreciation | Rs m | 462 | 28 | 1,675.5% | |
Interest | Rs m | 165 | 27 | 608.0% | |
Profit before tax | Rs m | 1,887 | 148 | 1,272.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 37 | 1,329.5% | |
Profit after tax | Rs m | 1,391 | 111 | 1,253.4% | |
Gross profit margin | % | 10.2 | 4.6 | 222.2% | |
Effective tax rate | % | 26.2 | 25.1 | 104.5% | |
Net profit margin | % | 6.3 | 6.5 | 96.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,166 | 828.7% | |
Current liabilities | Rs m | 5,025 | 952 | 528.0% | |
Net working cap to sales | % | 20.9 | 12.6 | 166.0% | |
Current ratio | x | 1.9 | 1.2 | 157.0% | |
Inventory Days | Days | 43 | 86 | 50.1% | |
Debtors Days | Days | 8 | 582 | 1.4% | |
Net fixed assets | Rs m | 11,017 | 1,291 | 853.4% | |
Share capital | Rs m | 587 | 766 | 76.6% | |
"Free" reserves | Rs m | 14,490 | 543 | 2,669.0% | |
Net worth | Rs m | 15,077 | 1,309 | 1,151.6% | |
Long term debt | Rs m | 0 | 181 | 0.0% | |
Total assets | Rs m | 20,684 | 2,457 | 841.7% | |
Interest coverage | x | 12.5 | 6.5 | 192.4% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 154.7% | |
Return on assets | % | 7.5 | 5.6 | 133.9% | |
Return on equity | % | 9.2 | 8.5 | 108.8% | |
Return on capital | % | 13.6 | 11.8 | 115.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 57 | 2,135.7% | |
From Investments | Rs m | -1,200 | -168 | 715.1% | |
From Financial Activity | Rs m | -41 | 91 | -45.2% | |
Net Cashflow | Rs m | -18 | -20 | 93.3% |
Indian Promoters | % | 48.2 | 30.8 | 156.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 17,000.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 69.2 | 74.8% | |
Shareholders | 130,003 | 170,079 | 76.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | AMBALAL SARABHAI | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | 0.06% | -0.44% |
1-Month | -4.43% | 8.37% | 2.15% |
1-Year | -4.01% | 117.99% | 49.82% |
3-Year CAGR | -11.98% | 32.98% | 14.21% |
5-Year CAGR | 15.37% | 27.17% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the AMBALAL SARABHAI share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of AMBALAL SARABHAI the stake stands at 30.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of AMBALAL SARABHAI.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
AMBALAL SARABHAI paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of AMBALAL SARABHAI.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.